414 related articles for article (PubMed ID: 32856961)
1. Clinical Relevance of Bladder Histopathological Findings and Their Impact on Treatment Outcomes among Patients with Interstitial Cystitis/Bladder Pain Syndrome: An Investigation of the European Society for the Study of Interstitial Cystitis Histopathological Classification.
Jhang JF; Hsu YH; Jiang YH; Ho HC; Kuo HC
J Urol; 2021 Jan; 205(1):226-235. PubMed ID: 32856961
[TBL] [Abstract][Full Text] [Related]
2. Relevance of the Endoscopic Evaluation in the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis.
Morlacco A; Mancini M; Soligo M; Zattoni F; Calpista A; Vizzielli G; Patti R; Mandato FG; Barneschi AC; Zattoni F; Iafrate M; Dal Moro F;
Urology; 2020 Oct; 144():106-110. PubMed ID: 32619597
[TBL] [Abstract][Full Text] [Related]
3. Cystoscopy and bladder biopsies in patients with bladder pain syndrome carried out following ESSIC guidelines.
Wyndaele JJ; Van Dyck J; Toussaint N
Scand J Urol Nephrol; 2009; 43(6):471-5. PubMed ID: 19707951
[TBL] [Abstract][Full Text] [Related]
4. Effect of amitriptyline in treatment interstitial cystitis or bladder pain syndrome according to two criteria: does ESSIC criteria change the response rate?
Sun Y; Fang Z; Ding Q; Zheng J
Neurourol Urodyn; 2014 Mar; 33(3):341-4. PubMed ID: 23744795
[TBL] [Abstract][Full Text] [Related]
5. Bladder pain syndrome/interstitial cystitis ESSIC type 3C: high expression of inducible nitric oxide synthase in inflammatory cells.
Logadottir Y; Hallsberg L; Fall M; Peeker R; Delbro D
Scand J Urol; 2013 Feb; 47(1):52-6. PubMed ID: 22775390
[TBL] [Abstract][Full Text] [Related]
6. Inflammation characteristics in bladder pain syndrome ESSIC type 3C/classic interstitial cystitis.
Logadottir Y; Delbro D; Lindholm C; Fall M; Peeker R
Int J Urol; 2014 Apr; 21 Suppl 1():75-8. PubMed ID: 24807505
[TBL] [Abstract][Full Text] [Related]
7. Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study.
Tomaszewski JE; Landis JR; Russack V; Williams TM; Wang LP; Hardy C; Brensinger C; Matthews YL; Abele ST; Kusek JW; Nyberg LM;
Urology; 2001 Jun; 57(6 Suppl 1):67-81. PubMed ID: 11378053
[TBL] [Abstract][Full Text] [Related]
8. Urothelial Functional Protein and Sensory Receptors in Patients With Interstitial Cystitis/Bladder Pain Syndrome With and Without Hunner's Lesion.
Jhang JF; Hsu YH; Kuo HC
Urology; 2016 Dec; 98():44-49. PubMed ID: 27575016
[TBL] [Abstract][Full Text] [Related]
9. ESSIC criteria for the diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC) and comparison with the NIDDK criteria.
Proaño A; Garde G; Garrido G; Mazza O
Arch Esp Urol; 2013 Mar; 66(2):206-14. PubMed ID: 23589598
[TBL] [Abstract][Full Text] [Related]
10. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of narrow band imaging-assisted transurethral electrocoagulation for ulcer-type interstitial cystitis/painful bladder syndrome.
Kajiwara M; Inoue S; Kobayashi K; Ohara S; Teishima J; Matsubara A
Int J Urol; 2014 Apr; 21 Suppl 1():57-60. PubMed ID: 24807500
[TBL] [Abstract][Full Text] [Related]
12. Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy.
Doiron RC; Tolls V; Irvine-Bird K; Kelly KL; Nickel JC
J Urol; 2016 Oct; 196(4):1136-40. PubMed ID: 27117441
[TBL] [Abstract][Full Text] [Related]
13. Clinical guidelines for interstitial cystitis/bladder pain syndrome.
Homma Y; Akiyama Y; Tomoe H; Furuta A; Ueda T; Maeda D; Lin AT; Kuo HC; Lee MH; Oh SJ; Kim JC; Lee KS
Int J Urol; 2020 Jul; 27(7):578-589. PubMed ID: 32291805
[TBL] [Abstract][Full Text] [Related]
14. Cytokine expression in patients with bladder pain syndrome/interstitial cystitis ESSIC type 3C.
Logadottir Y; Delbro D; Fall M; Gjertsson I; Jirholt P; Lindholm C; Peeker R
J Urol; 2014 Nov; 192(5):1564-8. PubMed ID: 24813342
[TBL] [Abstract][Full Text] [Related]
15. Bladder pain syndrome: do the different morphological and cystoscopic features correlate?
Geurts N; Van Dyck J; Wyndaele JJ
Scand J Urol Nephrol; 2011 Feb; 45(1):20-3. PubMed ID: 20846081
[TBL] [Abstract][Full Text] [Related]
16. Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C.
Gamper M; Viereck V; Eberhard J; Binder J; Moll C; Welter J; Moser R
Int Urogynecol J; 2013 Dec; 24(12):2049-57. PubMed ID: 23670165
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic and therapeutic efficacy of cystoscopy with hydrodistension and random biopsies in clinically suspected interstitial cystitis/bladder pain syndrome.
Chen Y; Ying Z; Xiao Y; Liu Y; Wu S
Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():156-161. PubMed ID: 34492610
[TBL] [Abstract][Full Text] [Related]
18. Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis?
Gamper M; Regauer S; Welter J; Eberhard J; Viereck V
J Urol; 2015 Jun; 193(6):1994-2000. PubMed ID: 25596361
[TBL] [Abstract][Full Text] [Related]
19. Hunner lesion versus non-Hunner lesion interstitial cystitis/bladder pain syndrome.
Whitmore KE; Fall M; Sengiku A; Tomoe H; Logadottir Y; Kim YH
Int J Urol; 2019 Jun; 26 Suppl 1():26-34. PubMed ID: 31144757
[TBL] [Abstract][Full Text] [Related]
20. Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome.
Walker SJ; Zambon J; Andersson KE; Langefeld CD; Matthews CA; Badlani G; Bowman H; Evans RJ
J Urol; 2017 Aug; 198(2):369-375. PubMed ID: 28202356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]